NiKang Therapeutics

About:

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Website: http://www.nikangtx.com/

Top Investors: BlackRock, RA Capital Management, Cormorant Asset Management, Perceptive Advisors, Invus

Description:

NiKang Therapeutics is an early-stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is informed by target structure biology and capitalizes on structure-based drug design enabling a rapid and efficient discovery and development of proprietary drug candidates with the most desirable pharmacological features into clinical studies.

Total Funding Amount:

$260M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wilmington, Delaware, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)nikangtx.com

Founders:

Yan Lou, Zhenhai Gao

Number of Employees:

11-50

Last Funding Date:

2021-05-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai